MONDAY, Feb. 28, 2022 (HealthDay News) — Settlements totaling $26 billion have been finalized between drugmaker Johnson & Johnson plus three major pharmaceutical distributors and state and local governments, over the companies’ role in America’s opioid crisis. The settlement plan — involving Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKessonContinue Reading

WEDNESDAY, Feb. 23, 2022 (HealthDay News) — The U.S. Food and Drug Administration has issued another pointed warning about the dangers posed by tianeptine, an antidepressant that is not approved for any type of medical treatment in the United States. Topping the list of possible risks from taking the drug:Continue Reading

TUESDAY, Feb. 22. 2022 (HealthDay News) — British Prime Minister Boris Johnson announced Monday that his government will end all remaining coronavirus restrictions in England, including the requirement for people with COVID-19 to self-isolate. In a news conference, Johnson said the country was moving to a model of personal responsibilityContinue Reading

FRIDAY, Feb. 18, 2022 (HealthDay News) — Several powdered infant formula products have been recalled by Abbott Inc., following reports of four infants developing bacterial infections after consuming the products, the U.S. Food and Drug Administration said Thursday. “As this is a product used as the sole source of nutritionContinue Reading